Interim analysis of a non-interventional study evaluating the quality of life in second-line treatment of metastatic renal cell carcinoma with everolimus (EVERPRO). 6. Juni 2014 Bergmann, L., Goebell, P., Kloß, S., Schirrmacher-Memel, S., Warnack, W., Kube, U., Scheffler, M., Doehn, C., Marschner, N., Rosé, C., Herrmann, E., 2014. Oncol Res Treat 37 (suppl.5)(P282), 89. doi:10.1159/000368945 Abstract Primary efficacy endpoint analysis of the CARIN trial: Capecitabine (Cap) and bevacizumab (Bev) with or without vinorelbine (Vin) in first line metastatic breast cancer (MBC). Welt, A., Lerchenmüller, C., Decker, T., Marschner, N., Salat, C., Hegewisch-Becker, S., 2013. Cancer Res 73 (24 Suppl)(P3-13-01). doi:10.1158/0008-5472.SABCS13-P3-13-01 Abstract… Weiterlesen Bendamustine-based first line therapy in chronic lymphocytic leukemia (CLL) in treatment routine: Interim results of the non-interventional study Be-CeLL1st. Ruffert, K., Aldaoud, A., Klausmann, M., Bruch, H.-R., Hansen, R., Losem, C., Frank, M., Straßl, L., 2014. Oncol Res Treat 37(suppl 5)(P194), 53–54. doi:10.1159/000368945… Weiterlesen